(Q40218001)

18 September 2017

siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations (English)

1 reference

18 September 2017

Masayoshi Konishi

1

1 reference

18 September 2017

Catherine H Wu

2

1 reference

18 September 2017

Masahiko Kaito

3

1 reference

18 September 2017

Kazuhiko Hayashi

4

1 reference

18 September 2017

Shozo Watanabe

5

1 reference

18 September 2017

Yukihiko Adachi

6

1 reference

18 September 2017

George Y Wu

7

1 reference

18 September 2017

language of work or name

1 reference

1 November 2006

1 reference

Journal of Viral Hepatitis

18 September 2017

1 reference

18 September 2017

13

1 reference

18 September 2017

11

1 reference

18 September 2017

756-761

1 reference

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Inhibition of hepatitis B virus expression and replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Interference of hepatitis A virus replication by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Efficient initiation of HCV RNA replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Resistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Quantitation of HCV RNA using real-time PCR and fluorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Short interfering RNA confers intracellular antiviral immunity in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Human immunodeficiency virus type 1 escape from RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00752.X

10.1111/J.1365-2893.2006.00752.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference